Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound anti-cancer drug

An anti-cancer drug and drug technology, applied in the field of biomedicine, can solve problems such as unsatisfactory treatment methods, individual differences in curative effect, drug resistance, recurrence rate, etc., and achieve the effect of inducing apoptosis and differentiation, good inhibitory effect, and low price

Inactive Publication Date: 2018-10-16
WUYI UNIV
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this treatment method is not ideal for non-APL AML patients, and the main treatment drugs are Cytarabine (Cytarabine) drugs
Even though breakthroughs have been made in the clinical treatment of acute myeloid leukemia, due to individual differences in efficacy, drug resistance, relapse rate and other refractory conditions, the development of low-toxic and effective drugs has become the key to controlling and reducing leukemia mortality. a major challenge

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound anti-cancer drug
  • Compound anti-cancer drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] A compound anticancer drug, the drug is composed of 12-oxo-tetradecanoylphorbol-13-acetate (TPA) and diethyldithiocarbamate with a mass ratio of 1:100 Ester (DTC) composition.

Embodiment 2

[0016] A compound anticancer drug, the drug is composed of 12-oxo-tetradecanoylphorbol-13-acetate (TPA) and diethyldithiocarbamate with a mass ratio of 1:250 Ester (DTC) composition.

Embodiment 3

[0018] A compound anticancer drug, the drug is composed of 12-oxo-tetradecanoylphorbol-13-acetate (TPA) and diethyldithiocarbamate with a mass ratio of 1:500 Ester (DTC) composition.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a compound anti-cancer drug. The drug consists of diethyl dithiocarbamate (DTC) and 12-oxo-tetradecanoyl phorbol-13-acetate (TPA). The novel anti-cancer drug, through combinedapplication of the phorbol compound (TPA) and the dithiocarbamate compound (DTC), can achieve an effect of conducting optimal treatment on cancers, with efficacy better than that of individual drugs,and a good inhibitory effect can be achieved on myeloid leukemia; in addition, the compound drug, in cancer treatment, is low in administration dosage and lower in administration concentration than individual drugs, so that toxic and side effects of the drug are reduced and harm to human body is relieved; and the compound anti-cancer drug is relatively low cheap, so that economic burden of patients is reduced.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to a composite anticancer drug. Background technique [0002] Cancer is a serious threat to people's lives and health. The latest edition of the "World Cancer Report" released by the World Health Organization (WHO) in 2014 predicts that cancer cases will show a rapid increase, from 14 million in 2012 to 19 million in 2025. million, and will reach 24 million by 2035. With the increase of people's life and work pressure and the change of diet structure, the probability of people suffering from cancer has increased significantly. The latest cancer status released by the National Cancer Center in 2017 shows that about 10,000 people are diagnosed with cancer every day in the country, and the incidence rate ranks 74th in the world. , the number of morbidity ranks first in the world; the death rate ranks 29th in the world. Cancer has seriously threatened the quality of life and life ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/27A61K31/23A61P35/02
CPCA61K31/23A61K31/27A61P35/02A61K2300/00
Inventor 马于然郑希李冬利张焜段庆
Owner WUYI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com